Amarin Corp Plc (AMRN)

[chas1232123]

PE - One of co-authors of the NEJM editorial email Matt Herper that he thought V should be used. Matt included it in his Nov 20 follow-up article.

From Forbes online Nov 20:

"Should doctors use Vascepa? “They should use it,” Kastelein wrote via email. “The only thing we are waiting for is to learn whether Vascepa is unique or other fish-oil preparations or other doses of EPA have less, similar or better efficacy.”